Literature DB >> 19546164

Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats?

Emilie Roudier1, Natalie Chapados, Simon Decary, Charlotte Gineste, Catherina Le Bel, Jean-Marc Lavoie, Raynald Bergeron, Olivier Birot.   

Abstract

Skeletal muscle capillarisation responds to physiological and pathological conditions with a remarkable plasticity. Angiomotin was recently identified as a new pro-angiogenic molecule. Angiomotin is expressed as two protein isoforms, p80 and p130. Whereas p80 stimulates endothelial cell migration and angiogenesis, p130 is rather characteristic of stabilized and matured vessels. To date, how angiomotin expression is physiologically regulated in vivo remains largely unknown. We thus investigated (1) whether angiomotin was physiologically expressed in skeletal muscle; (2) whether exercise training, known to stimulate muscle angiogenesis, affected angiomotin expression; and (3) whether such regulation was altered in obesity, a pathological situation often associated with an impaired angiogenic activity and some capillary rarefaction in skeletal muscle. Two models of obesity were used: a high fat diet regime and Zucker Diabetic Fatty rats (ZDF). Our results provide evidence that angiomotin was expressed both in capillaries and myofibres. In non-obese rats, the p80 isoform was increased in plantaris muscle in response to endurance training whereas p130 was unaffected. In obese animals, no change was observed for p80 whereas training significantly decreased p130 expression. Exercise training induced angiogenesis in plantaris from both obese and non-obese rats, possibly through the modulation of angiomotin level and its consequences on RhoA-ROCK signalling. In conclusion, any increase in p80 or decrease in p130, as respectively observed in non-obese and obese animals, led to an increased ratio between p80 and p130 isoforms. This increased angiomotin p80/p130 ratio might then directly reflect the enhanced angiogenic ability of skeletal muscle in response to exercise training.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546164      PMCID: PMC2756441          DOI: 10.1113/jphysiol.2009.175554

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  38 in total

1.  Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis.

Authors:  Marcus Fruttiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-02       Impact factor: 4.799

2.  Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.

Authors:  Raynald Bergeron; Jun Yao; John W Woods; Emanuel I Zycband; Cherrie Liu; Zhihua Li; Alan Adams; Joel P Berger; Bei B Zhang; David E Moller; Thomas W Doebber
Journal:  Endocrinology       Date:  2006-05-25       Impact factor: 4.736

3.  The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells.

Authors:  Mira Ernkvist; Nathalie Luna Persson; Stéphane Audebert; Patrick Lecine; Indranil Sinha; Miaoliang Liu; Marc Schlueter; Arie Horowitz; Karin Aase; Thomas Weide; Jean-Paul Borg; Arindam Majumdar; Lars Holmgren
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

Review 4.  Mechanisms of angiogenesis.

Authors:  W Risau
Journal:  Nature       Date:  1997-04-17       Impact factor: 49.962

5.  p130-angiomotin associates to actin and controls endothelial cell shape.

Authors:  Mira Ernkvist; Karin Aase; Chinwe Ukomadu; James Wohlschlegel; Ryan Blackman; Niina Veitonmäki; Anders Bratt; Anindya Dutta; Lars Holmgren
Journal:  FEBS J       Date:  2006-05       Impact factor: 5.542

6.  Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration.

Authors:  J G Garcia; A D Verin; M Herenyiova; D English
Journal:  J Appl Physiol (1985)       Date:  1998-05

7.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Authors:  A Rivard; M Silver; D Chen; M Kearney; M Magner; B Annex; K Peters; J M Isner
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Angiomotin regulates endothelial cell migration during embryonic angiogenesis.

Authors:  Karin Aase; Mira Ernkvist; Lwaki Ebarasi; Lars Jakobsson; Arindam Majumdar; Chunling Yi; Olivier Birot; Yue Ming; Anders Kvanta; Dan Edholm; Pontus Aspenström; Joseph Kissil; Lena Claesson-Welsh; Akihiko Shimono; Lars Holmgren
Journal:  Genes Dev       Date:  2007-08-15       Impact factor: 11.361

9.  Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer.

Authors:  Wen G Jiang; Gareth Watkins; Anthony Douglas-Jones; Lars Holmgren; Robert E Mansel
Journal:  BMC Cancer       Date:  2006-01-23       Impact factor: 4.430

10.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.

Authors:  Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539

View more
  20 in total

1.  Angio-adaptation in unloaded skeletal muscle: new insights into an early and muscle type-specific dynamic process.

Authors:  Emilie Roudier; Charlotte Gineste; Alexandra Wazna; Kooroush Dehghan; Dominique Desplanches; Olivier Birot
Journal:  J Physiol       Date:  2010-09-27       Impact factor: 5.182

2.  The Amotl2 gene inhibits Wnt/β-catenin signaling and regulates embryonic development in zebrafish.

Authors:  Zhiqiang Li; Yeqi Wang; Min Zhang; Pengfei Xu; Huizhe Huang; Di Wu; Anming Meng
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

3.  Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Robert W Brock; I Mark Olfert; Evan R DeVallance; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

4.  YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.

Authors:  Shuai Ye; Matthew A Lawlor; Adrian Rivera-Reyes; Shaun Egolf; Susan Chor; Koreana Pak; Gabrielle E Ciotti; Avery C Lee; Gloria E Marino; Jennifer Shah; David Niedzwicki; Kristy Weber; Paul M C Park; Md Zahidul Alam; Alison Grazioli; Malay Haldar; Mousheng Xu; Jennifer A Perry; Jun Qi; T S Karin Eisinger-Mathason
Journal:  Cancer Res       Date:  2018-02-28       Impact factor: 12.701

Review 5.  The Angiomotins--from discovery to function.

Authors:  Susana Moleirinho; William Guerrant; Joseph L Kissil
Journal:  FEBS Lett       Date:  2014-02-15       Impact factor: 4.124

6.  Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors.

Authors:  J Stalin; M Nollet; P Garigue; S Fernandez; L Vivancos; A Essaadi; A Muller; R Bachelier; A Foucault-Bertaud; L Fugazza; A S Leroyer; N Bardin; B Guillet; F Dignat-George; M Blot-Chabaud
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

7.  Murine double minute-2 expression is required for capillary maintenance and exercise-induced angiogenesis in skeletal muscle.

Authors:  Emilie Roudier; Paul Forn; Mary Ellen Perry; Olivier Birot
Journal:  FASEB J       Date:  2012-07-26       Impact factor: 5.191

Review 8.  Exercise training and peripheral arterial disease.

Authors:  Tara L Haas; Pamela G Lloyd; Hsiao-Tung Yang; Ronald L Terjung
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

9.  The vasculome of the mouse brain.

Authors:  Shuzhen Guo; Yiming Zhou; Changhong Xing; Josephine Lok; Angel T Som; MingMing Ning; Xunming Ji; Eng H Lo
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Identification of Key Pathways and Genes in Obesity Using Bioinformatics Analysis and Molecular Docking Studies.

Authors:  Harish Joshi; Basavaraj Vastrad; Nidhi Joshi; Chanabasayya Vastrad; Anandkumar Tengli; Iranna Kotturshetti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.